6.
Garcia-Calvo M, Lisnock J, Bull H, Hawes B, Burnett D, Braun M
. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci U S A. 2005; 102(23):8132-7.
PMC: 1149415.
DOI: 10.1073/pnas.0500269102.
View
7.
Jia L, Betters J, Yu L
. Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Annu Rev Physiol. 2010; 73:239-59.
PMC: 3965667.
DOI: 10.1146/annurev-physiol-012110-142233.
View
8.
Petersen N, Faergeman N, Faegeman N, Yu L, Wustner D
. Kinetic imaging of NPC1L1 and sterol trafficking between plasma membrane and recycling endosomes in hepatoma cells. J Lipid Res. 2008; 49(9):2023-37.
DOI: 10.1194/jlr.M800145-JLR200.
View
9.
Liu G, Zhou L, Zhang H, Chen R, Zhang Y, Li L
. Regulation of hepatic lipogenesis by the zinc finger protein Zbtb20. Nat Commun. 2017; 8:14824.
PMC: 5364431.
DOI: 10.1038/ncomms14824.
View
10.
Weinglass A, Kohler M, Schulte U, Liu J, Nketiah E, Thomas A
. Extracellular loop C of NPC1L1 is important for binding to ezetimibe. Proc Natl Acad Sci U S A. 2008; 105(32):11140-5.
PMC: 2516253.
DOI: 10.1073/pnas.0800936105.
View
11.
Xie C, Li N, Chen Z, Li B, Song B
. The small GTPase Cdc42 interacts with Niemann-Pick C1-like 1 (NPC1L1) and controls its movement from endocytic recycling compartment to plasma membrane in a cholesterol-dependent manner. J Biol Chem. 2011; 286(41):35933-35942.
PMC: 3195612.
DOI: 10.1074/jbc.M111.270199.
View
12.
Ge L, Wang J, Qi W, Miao H, Cao J, Qu Y
. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab. 2008; 7(6):508-19.
DOI: 10.1016/j.cmet.2008.04.001.
View
13.
Pramfalk C, Jiang Z, Cai Q, Hu H, Zhang S, Han T
. HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver. J Lipid Res. 2010; 51(6):1354-62.
PMC: 3035498.
DOI: 10.1194/jlr.M900274.
View
14.
Ference B, Ginsberg H, Graham I, Ray K, Packard C, Bruckert E
. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017; 38(32):2459-2472.
PMC: 5837225.
DOI: 10.1093/eurheartj/ehx144.
View
15.
Zhang Y, Fu Z, Wei J, Qi W, Baituola G, Luo J
. A variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption. Science. 2018; 360(6393):1087-1092.
DOI: 10.1126/science.aao6575.
View
16.
Soppert J, Lehrke M, Marx N, Jankowski J, Noels H
. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020; 159:4-33.
DOI: 10.1016/j.addr.2020.07.019.
View
17.
Johnson T, Pfeffer S
. Ezetimibe-sensitive cholesterol uptake by NPC1L1 protein does not require endocytosis. Mol Biol Cell. 2016; 27(11):1845-52.
PMC: 4884074.
DOI: 10.1091/mbc.E16-03-0154.
View
18.
Temel R, Tang W, Ma Y, Rudel L, Willingham M, Ioannou Y
. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest. 2007; 117(7):1968-78.
PMC: 1888567.
DOI: 10.1172/JCI30060.
View
19.
Alrefai W, Annaba F, Sarwar Z, Dwivedi A, Saksena S, Singla A
. Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: Role of sterol regulatory element binding protein 2. Am J Physiol Gastrointest Liver Physiol. 2006; 292(1):G369-76.
DOI: 10.1152/ajpgi.00306.2006.
View
20.
Benjamin E, Muntner P, Alonso A, Bittencourt M, Callaway C, Carson A
. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019; 139(10):e56-e528.
DOI: 10.1161/CIR.0000000000000659.
View